ArticleScientific reports2025
Predictors associated with time to default for HIV/AIDS patients under HAART at Debre Tabor Referral Hospital: a Cox regression model.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The human immunodeficiency virus systematically undermines the immune system, which serves as our body's inherent safeguard against diseases. Currently, it is the most serious threat to public health. Ethiopia is among the countries with the highest prevalence of HIV/AIDS. Defaulting is still a public health issue that must be resolved in order to maximize HAART's benefits. Thus, this study was aimed to assess the proportion of HAART defaulters and to identify associated factors that lead to defaulting from HAART. Data from 230 study participants was analyzed using a Cox PH regression model. The study found that patients who did not adhere to at least 95% of their regimen had a higher risk of defaulting from HAART relative to those who did adhere to at least 95% [HR = 2.924, 95% CI: 2.113, 4.047]. To advance the longevity of HIV/AIDS-infected patients within HAART medication, an intervention should be taken from the concerned body for those patients who had been at high risk of defaulting during initial and some stages of treatment. Interventions might include: following home-based treatment options; mobile health technology; granting access road facilities; accessing fast diagnostic testing procedure; giving medical advice to disclose; giving receive financial support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.